CMC Pharmaceuticals, Inc.

CMC Pharma is a leading contract development and manufacturing organization (CDMO) committed to helping pharmaceutical and biotech companies develop new and better drug products. We provide exceptional drug product R&D services including formulation and analytical development, stability evaluations, drug delivery system design, and prototype preparation services. We are experts in innovative and complex delivery systems including polymeric controlled release, in situ forming gels, suspensions, and more. We focus on pharmaceutical projects that require wide ranging consulting services, pre-formulation characterization, formulation development, analytical chemistry, stability evaluation, novel drug delivery systems, process development and drug product characterization studies. Our capabilities and services are appropriate for programs from early to late-stage development through FDA approval and commercial launch. CMC utilizes a consortium of seasoned PhD chemists and engineers that provide Chemistry, Manufacturing, and Controls expertise to the pharmaceutical industry. CMC’s President, Mike Radomsky, has a PhD in chemical engineering from The Johns Hopkins University and 25 years of experience in the pharmaceutical industry. Radomsky is the inventor and author of dozens of patents and scientific publications focused on the formulation and manufacture of drug products. Much like Radomsky, our employees have been everywhere – From Big pharma to emerging start-ups. Our pharmaceutical scientists typically each have more than two decades of experience in the pharmaceutical or biotech industry. This experience in pharmaceutical development and our modern R&D laboratory are ideally suited to meet all of your drug product development needs.